<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells resemble stem cells in expression signatures leading them to share some features, most notably, self-renewal </plain></SENT>
<SENT sid="1" pm="."><plain>A complex network of transcription factors and signaling molecules are required for continuance of this trait </plain></SENT>
<SENT sid="2" pm="."><plain>SALL4 is a zinc finger transcriptional activator crucial for maintenance of self-renewal in stem cells; however, its expression level has not yet been elucidated in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>To determine this level and probable clinicopathological consequences, its expression was analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: SALL4 expression in fresh tumoral and distant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-free tissues from 46 colorectal samples was compared by real-time polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Greater than a two-fold increase in SALL4 expression was detected in 87% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> vs. <z:mpath ids='MPATH_458'>normal</z:mpath> related tissues </plain></SENT>
<SENT sid="6" pm="."><plain>SALL4 expression was significantly correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">metastasis to lymph nodes</z:e>, especially in moderately-differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, higher levels of SALL4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression were significantly associated with younger than older patients with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in stages I and II (P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These results indicate a relationship between SALL4 expression and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">metastasis to lymph nodes</z:e> and consequent advancement of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> to advanced stages III and IV </plain></SENT>
<SENT sid="9" pm="."><plain>Along with the promising evidence of its role in self-renewal in various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, SALL4 may have a role in progression, development and maintenance of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
</text></document>